5HT2C receptor agonists and antagonists in animal models of anxiety

Author： Martin J.R.   Bouml s M.   Jenck F.   Kouml hler C.   Moreau J.-L.   Sleight A.J.   Stadler H.   Wichmann J.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 209-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of RO 60 0175, a 5-HT 2C receptor agonist, in three animal models of anxiety

By Kennett G.   Lightowler S.   Trail B.   Bright F.   Bromidge S.  

European Journal of Pharmacology, Vol. 387, Iss. 2, 2000-01 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

New 5-HT2C receptor agonists

By Bishop Michael J   Nilsson Björn M  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite

Antiaversive effects of 5HT 2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats

By Jenck F.   Moreau J.-L.   Berendsen H.H.G.   Boes M.   Broekkamp C.L.E.   Martin J.R.   Wichmann J.   Van Delft A.M.L.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 383-387

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT 2C receptor antagonists enhance the behavioural response to dopamine D 1 receptor agonists in the 6-hydroxydopamine-lesioned rat

By Fox S.H.   Brotchie J.M.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite